Setmelanotide
( DrugBank: Setmelanotide / KEGG DRUG: Setmelanotide, Setmelanotide acetate )
5 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 134 | Septo-optic dysplasia | 1 |
| 193 | Prader-Willi syndrome | 1 |
| 202 | Smith-Magenis syndrome | 3 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 236 | Pseudohypoparathyroidism | 1 |
| 265 | Lipodystrophy | 1 |
134. Septo-optic dysplasia
Clinical trials : 3 / Drugs : 3 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 3
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
193. Prader-Willi syndrome
Clinical trials : 140 / Drugs : 137 - (DrugBank : 26) / Drug target genes : 51 - Drug target pathways : 64
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
202. Smith-Magenis syndrome
Clinical trials : 9 / Drugs : 10 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 4
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
236. Pseudohypoparathyroidism
Clinical trials : 6 / Drugs : 5 - (DrugBank : 3) / Drug target genes : 20 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
265. Lipodystrophy
Clinical trials : 133 / Drugs : 176 - (DrugBank : 58) / Drug target genes : 30 - Drug target pathways : 102
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|